Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
C-MER Eye Care Holdings Limited ( (HK:3309) ) just unveiled an announcement.
Shareholders of C-MER Medical Holdings Limited have approved all resolutions at the company’s annual general meeting held on 20 May 2026, with voting conducted by poll in accordance with Hong Kong listing rules. The meeting endorsed the audited financial statements for the year ended 31 December 2025, confirmed PricewaterhouseCoopers as auditor, and authorised the board to fix directors’ and auditor’s remuneration.
Investors also backed a final dividend of HK2.0 cents per share and a special dividend of HK1.0 cent, signalling continued capital returns to shareholders. The AGM further re-elected all proposed independent non-executive directors and renewed general mandates for share repurchases and new share issuances, providing the board with flexibility for future capital management and supporting the company’s corporate governance structure.
More about C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited is a Hong Kong-listed healthcare group focused on medical services, particularly in ophthalmology and related specialties. The company operates within the broader medical and clinical services industry, providing specialised care to patients in Hong Kong and potentially other markets in the region.
Average Trading Volume: 398,489
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.42B
Find detailed analytics on 3309 stock on TipRanks’ Stock Analysis page.